Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: Randomised controlled trial

British Medical Journal

Volumn 319, Issue 7210, 1999, Pages 612-615

  Peveler, Robert ^a   George, Charles ^a   Kinmonth, Ann Louise ^a   Campbell, Michael ^a   Thompson, Chris ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DOSULEPIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITOR; PATIENT COUNSELING; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; UNITED KINGDOM;

EID: 0033523392     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7210.612     Document Type: Article

References (20)

1. 1 Robins LN, Helzer JE, Weismann MM, Orvaschel H, Gruenberg E, Burke JD, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiat 1984;41:949-58.
2. 2 Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press, 1996.
3. 3 Goldberg DP, Bridges K. Invited review: somatic presentations of psychiatric illness in primary care setting. J Psychosom Res 1988;32:437-44.
4. 4 Hollyman JA, Freeling P, Paykel ES. Double blind placebo controlled trial of amitriptyline among depressed patients in general practice. J R Coll Gen Pract 1988;38:393-7.
5. 5 Johnson DAW. Treatment of depression in general practice. BMJ 1973;266:18-20.
6. 6 Johnson DAW. A study of the use of antidepressant medication in general practice. Br J Psychiat 1974;125:186-92.
7. 7 Katon W, Von Kortf M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:67-76.
8. 8 Lin EHB, Von Korll M, Katon W, Bush T, Simon GE, Walker E, Robinson P. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 1995;33:67-74.
9. 9 Maddox JC, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharm 1994;8:48-53.
10. 10 Cramer JA, Spilker B. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991.
11. 11 Haynes RB, McKibhon KA, Kanani R, Brouwers C, Oliver T. Interventions to assist patients to follow prescriptions for medications. In: Cochrane Collaboration: Cochrane Library Oxford: Update Software, 1998.
12. 12 Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: a randomised controlled trial. BMJ 1996;312:345-9.
13. 13 Wilkinson G, Allen P, Marshall E, Walker J, Browne W, Mann AH. The role of the practice nurse in the management of depression in general practice: treatment adherence to antidepressant medication. Psychol Med 1993;23:229-37.
14. 14 Gibbs S, Waters WE, George CF. The benefits of prescription information leaflets. Br J Clin Pharmacol 1989;27:273-39.
15. 15 Gibbs S, Waters WE, George CF. The design of prescription information leaflets and feasibility of their use in general practice. Pharm Med 1987;2:23-34.
16. 16 European Economic Community. Council directive 92/27/EEC on the labelling of medicinal products for human use and on package leaflets. Official Journal of the European Communities 1992;1:113,8-12.
17. 17 American Psychiatric Association. DSM-III-R. Washington, DC: APA, 1987.
18. 18 Zigmund A, Smith R. The hospital anxiety and depression scale. Acta Psychiat Scand 1983;67:361-70.
19. 19 Ware JE. Measuring patients' views: the optimum outcome measure. BMJ 1993;306:1429-30.
20. 20 Campbell MJ, Julious SA, Altman DG. Sample sizes for binary, ordered categorical, and continuous outcome in two group comparisons. BMJ 1993;311:1145-8.